Chairman

Simon Cartmell, OBE

Simon Cartmell is a seasoned business leader with extensive experience in both pharmaceuticals and medical devices. He successfully led ApaTech from a university spin-out to a $330 million acquisition by Baxter International. Simon has also served as an Operating Partner with a prominent UK venture capital firm. Currently, among other assignments, he is Chairman of OssDsign, a spinal biologics company focusing on US expansion, and MatOrtho, a leading UK joint reconstruction business.